drugset / Trial / NCT02640183

EMLA Cream in Hysteroscopy Practice

NCT02640183

Phase 2 Unknown 184 enrolled Ain Shams Maternity Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to investigate the efficacy of 5% lidocaine 25 mg-prilocaine 25 mg/g cream (EMLA®) applied to the uterine cervix for reducing pain during diagnostic hysteroscopy, using a visual analogue scale (VAS) for pain, and whether it can replace general anesthesia that may be required for some cases of office hysteroscopy.

Timeline

Start
2015-09
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine-Prilocaine Unknown 3 ml Topical

Indications

No indication recorded.